Although entrepreneurs and venture investors typically drive the negotiation of the term sheet for a venture financing, once the term sheet is executed, the commercial parties (especially those who have not been through the process many times) often feel sidelined in the ensuing process to close and uncomfortable with their lack of visibility into and control over the timeline. Accordingly, I thought it would be helpful to provide a high-level overview of a standard venture financing timeline.
Continue Reading

Below are three charts compliments of J.Thelander Consulting and PitchBook that illustrate the dilutive impact over time of venture funding on founder ownership levels. These charts are the result of J.Thelander Consulting’s venture-backed private company ownership survey – and divided by industry (biotechnology, medical device and technology). Read the full article here.

While these charts are directionally helpful, each company will of course have its own set of facts. In my experience, the main drivers of founder dilution are often:

  • the size of the founder team;
  • how long the


Continue Reading

By Tyler Hollenbeck and Cisco Palao-Ricketts

Although there a number of web resources regarding the distinctions between “incentive stock options” (ISOs), which can only be granted to employees, and “non-statutory options” (NSOs)[1], which can be granted to employees, directors and consultants, these resources are often heavy with tax jargon that is difficult to understand.  To help entrepreneurs focus on what should be most important to them, we have put together the below quick reference guide[2].

I.  TAX CONSEQUENCES – TO THE INDIVIDUAL

A.  NSOs

  • At date


Continue Reading